 |
| Ligand ID: ILE Drugbank ID: DB00167(L-Isoleucine) Indication:The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity. |
| DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
|---|---|---|---|---|---|---|---|---|---|---|
 Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 1z1i | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ALA A 173TYR A 182VAL A 114HIS A 172 | 1.42A | 19.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE B1213ALA B1255THR B1257VAL B1297 | 1.12A | 19.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2amd | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE A 213ALA A 255THR A 257VAL A 297 | 1.07A | 18.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2c3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE A 213ALA A 255THR A 257VAL A 297 | 0.97A | 19.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2cjr | NUCLEOCAPSID PROTEIN (SARS-COVTW1) | 4 / 6 | ILE H 321ALA G 337THR H 333HIS G 335 | 0.99A | 13.50 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2dd8 | IGG LIGHT CHAIN (Homosapiens) | 4 / 6 | ILE L 75ALA L 84VAL L 104VAL L 47 | 1.06A | 16.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 6 | THR C 35VAL C 42TYR C 28VAL C 8 | 1.50A | 20.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 6 | THR B 171VAL B 203VAL B 117HIS B 172 | 1.51A | 20.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2gt8 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE A 213ALA A 255THR A 257VAL A 297 | 1.03A | 18.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2op9 | REPLICASEPOLYPROTEIN 1AB(PP1AB, ORF1AB)3C-LIKE PROTEINASE(3CL-PRO, 3CLP) (SARSr-CoV) | 4 / 6 | ILE A 213ALA A 255THR A 257VAL A 297 | 0.99A | 18.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 4 / 6 | ILE A 213ALA A 255THR A 257VAL A 297 | 1.08A | 19.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2qc2 | 3C-LIKE PROTEINASE (-) | 4 / 6 | ILE B 213ALA B 255THR B 257VAL B 297 | 1.05A | 18.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2qcy | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE A 213ALA A 255THR A 257VAL A 297 | 1.09A | 19.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2w2g | NSP3 (SARSr-CoV) | 4 / 6 | ALA B 540VAL B 578TYR B 564HIS B 539 | 1.47A | 19.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2xyq | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 6 | ALA A 83THR A 82VAL A 84TYR A 47 | 1.45A | 20.80 | NoneNoneNoneSAH A1293 (-4.8A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 2xyr | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 6 | ALA A 83THR A 82VAL A 84TYR A 47 | 1.46A | 21.26 | NoneNoneNoneSFG A1298 (-4.6A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3d0g | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 6 | ALA B 403VAL B 404TYR B 381VAL B 573 | 1.47A | 20.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3d62 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE A 213ALA A 255THR A 257VAL A 297 | 1.07A | 19.41 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3e91 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE B 213ALA B 255THR B 257VAL B 297 | 1.10A | 19.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3e9s | NSP3 (SARSr-CoV) | 4 / 6 | THR A 35VAL A 42TYR A 28VAL A 8 | 1.47A | 20.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3eaj | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE B 213ALA B 255THR B 257VAL B 297 | 1.01A | 19.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3ebn | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 6 | ILE A 213ALA C 255THR C 257VAL C 297 | 0.96A | 11.82 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3ee7 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 6 | ALA A 107THR A 109VAL A 110VAL B 110 | 1.36A | 11.30 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE B 213ALA B 255THR B 257VAL B 297 | 1.00A | 18.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3f9h | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE A 213ALA A 255THR A 257VAL A 297 | 0.97A | 18.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3fzd | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE A 213ALA A 255THR A 257VAL A 297 | 1.07A | 19.23 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE B 213ALA B 255THR B 257VAL B 297 | 1.10A | 19.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3m3t | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE A 213ALA A 255THR A 257VAL A 297 | 1.04A | 18.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE A 213ALA A 255THR A 257VAL A 297 | 1.08A | 18.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 3r24 | 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 6 | ALA A 83THR A 82VAL A 84TYR A 47 | 1.43A | 20.21 | NoneNoneNoneSAM A 302 (-4.5A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE A 213ALA A 255THR A 257VAL A 297 | 1.00A | 18.82 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 6 | THR A 171VAL A 203VAL A 117HIS A 172 | 1.48A | 19.28 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 6 | THR A 35VAL A 42TYR A 28VAL A 8 | 1.45A | 19.28 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 4mds | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE A 213ALA A 255THR A 257VAL A 297 | 1.04A | 19.20 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 4mm3 | PAPAIN-LIKEPROTEINASE (SARSr-CoV) | 4 / 6 | THR B 171VAL B 203VAL B 117HIS B 172 | 1.51A | 20.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 4mm3 | PAPAIN-LIKEPROTEINASE (SARSr-CoV) | 4 / 6 | THR B 35VAL B 42TYR B 28VAL B 8 | 1.44A | 20.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5b6o | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE B 213ALA B 255THR B 257VAL B 297 | 1.03A | 19.45 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5c5o | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | ILE B 213ALA B 255THR B 257VAL B 297 | 1.05A | 19.56 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 4 / 6 | VAL B 421TYR B 296VAL B 290HIS B 427 | 1.50A | 21.30 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 4 / 6 | VAL D 421TYR D 296VAL D 290HIS D 427 | 1.51A | 21.75 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5c8u | GUANINE-N7METHYLTRANSFERASENSP10 (SARSr-CoV) | 4 / 6 | ALA C 71THR D 21TYR C 96VAL D 29 | 1.38A | 14.04 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5c8u | GUANINE-N7METHYLTRANSFERASENSP10 (SARSr-CoV) | 4 / 6 | ALA C 71THR D 21TYR C 96VAL D 29 | 1.32A | 14.04 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 4 / 6 | ALA N 71THR B 21TYR N 96VAL B 29 | 1.37A | 13.78 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 4 / 6 | ALA N 71THR B 21TYR N 96VAL B 29 | 1.29A | 13.78 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 6 | THR B 171VAL B 203VAL B 117HIS B 172 | 1.45A | 20.21 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5tl7 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 6 | THR D 35VAL D 42TYR D 28VAL D 8 | 1.38A | 20.21 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5wrg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | ALA A 857THR A 856VAL A 860VAL A 767 | 1.40A | 18.97 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 6 | ALA B 864THR B 863VAL B 860VAL B1047 | 1.03A | 18.93 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 6 | ALA A 864THR A 863VAL A 860VAL A1047 | 1.29A | 18.93 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 6 | ALA A 864THR A 863VAL A 860VAL A1047 | 1.08A | 18.93 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5x5f | S PROTEIN (MERS-CoV) | 4 / 6 | ALA C 671THR C 672VAL C 718HIS C 670 | 1.26A | 17.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5x5f | S PROTEIN (MERS-CoV) | 4 / 6 | ALA B 282TYR B 241VAL B 286HIS B 264 | 1.40A | 17.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | ALA B 864THR B 863VAL B 860VAL B1047 | 1.12A | 18.97 | ALA B 864 ( 0.0A)THR B 863 ( 0.8A)VAL B 860 ( 0.6A)VAL B1047 ( 0.6A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5y3q | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 6 | THR A 171VAL A 203VAL A 117HIS A 172 | 1.51A | 20.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 5y3q | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 6 | THR A 35VAL A 42TYR A 28VAL A 8 | 1.50A | 20.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | ALA A 864THR A 863VAL A 860VAL A1047 | 1.31A | 18.97 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | ALA A 864THR A 863VAL A 860VAL A1047 | 1.08A | 18.97 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | ALA B 864THR B 863VAL B 860VAL B1047 | 1.08A | 18.97 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 6 | ALA C 864THR C 863VAL C 860VAL C1047 | 1.15A | 18.23 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 6 | ALA C 864THR C 863VAL C 860VAL C1047 | 1.39A | 18.23 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 6 | ALA A 857THR A 856VAL A 860VAL A 767 | 1.45A | 18.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 6 | ALA A 864THR A 863VAL A 860VAL A1047 | 1.21A | 18.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 6jyt | HELICASE (SARSr-CoV) | 4 / 6 | ALA B 454VAL B 456TYR B 457VAL B 449 | 1.48A | 20.31 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | ALA B 864THR B 863VAL B 860VAL B1047 | 1.15A | 19.01 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | ALA B 864THR B 863VAL B 860VAL B1047 | 1.41A | 19.01 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_A_ILEA602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 6nus | NSP12 (SARSr-CoV) | 4 / 6 | ALA A 702THR A 701VAL A 704VAL A 476 | 1.29A | 21.03 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 6nus | NSP12 (SARSr-CoV) | 4 / 6 | ALA A 379VAL A 330VAL A 398HIS A 381 | 1.35A | 21.03 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ECL_D_ILED602_0 (JASMONIC ACID-AMIDOSYNTHETASE JAR1) | 6nus | NSP12NSP8 (SARSr-CoV) | 4 / 6 | ILE B 119ALA A 382VAL A 398VAL A 330 | 0.90A | 16.79 | None |